SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is trending as investors aggressively bid up memory and storage stocks, driven by reports of persistent supply constraints and major hardware price hikes. The community remains deeply polarized, with bulls pointing to the ongoing AI infrastructure supercycle while vocal bears argue the stock's parabolic ascent represents an overextended bubble nearing a potential crash.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is gaining momentum following a new joint research agreement with Honda, which confirms the solid-state battery platform has cleared rigorous technical evaluations and testing by a major automotive OEM. Investors and community members are interpreting this validation as a crucial de-risking event that expands the companys ecosystem beyond its existing partnership with Volkswagen, fueling active discussion about potential scaling timelines and future announcements from additional automakers.

Roundhill ETF Trust - Roundhill Memory ETF

DRAM is surging as investors pivot toward memory chip manufacturers, which are increasingly viewed as the critical bottleneck for AI infrastructure. The community is actively debating the transition from cyclical, boom-bust trading to a long-term structural re-rating driven by multi-year demand from hyperscalers.

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

Butterfly Network Inc - Ordinary Shares - Class A

Butterfly Network Inc

Butterfly Network is trending following a significant rally driven by investor excitement over its partnership with AI startup Midjourney to develop a new ultrasound-powered full-body scanner. While the community is actively debating the company's long-term potential in medical imaging versus concerns over its path to profitability and potential share dilution, sentiment remains charged by high trading volume and discussions regarding a possible short squeeze.

Accenture is a global professional services company that helps the world’s businesses, governments and other organizations build their digital core, optimize their operations, accelerate revenue growth and enhance citizen services, creating tangible value at speed and scale. The firm combines technology and leadership in cloud, data and AI with industry experience, functional expertise and global delivery capability. Its services include Strategy & Consulting, Technology, Operations, Industry X, and Song. It operates through the following geographical segments: North America, EMEA, and Growth Markets. The company was founded in 1989 and is headquartered in Dublin, Ireland.

Accenture plc - Ordinary Shares - Class A

Accenture shares are experiencing significant volatility as investors digest a fiscal revenue growth outlook adjustment alongside ongoing debates about the long-term impact of AI on the consulting business model. While some community members are betting on a valuation reset and strong dividend fundamentals, others are actively debating whether automated tools are permanently displacing the need for traditional IT services.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

Taiwan Semiconductor is hitting all-time highs as community members highlight its irreplaceable role as the foundry backbone of the AI hardware ecosystem and the primary producer of advanced AI chips. Investor enthusiasm remains elevated due to massive capex commitments, sustained supply chain bottlenecks, and growing confidence that the company maintains significant pricing power amid insatiable demand.

The Kroger Co. engages in the retail grocery business with added convenience to retail pharmacies and fuel centers. Its main focus is on growing households and increasing customer loyalty by delivering great value and convenience, and investing in four strategic pillars: Fresh, Brands, Data & Personalization and Seamless. Its brands include Big K, Smart Way, Heritage Farm, Simple Truth, and Simple Truth Organic. The company was founded by Barney Kroger in 1883 and is headquartered in Cincinnati, OH.

Kroger Co.

Kroger is trending as investors weigh a recent leadership search and ongoing competitive pressures, with the community actively debating its long-term value as a defensive staple amid broader market volatility. Many traders are focused on identifying entry points following recent price consolidation, viewing the stock as a reliable hold while monitoring its potential for a rebound toward previous highs.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors and social media users fiercely debate the administration's recent memorandum with Iran, with critics labeling it a strategic failure and a massive financial liability. The community remains deeply polarized, with intense arguments centered on the geopolitical impact, the transparency of the deal's terms, and the broader implications for US foreign policy and market stability.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna (MRNA) is trending following a unanimous FDA advisory committee endorsement for its mRNA-based influenza vaccine, a catalyst that has sparked significant options activity and bullish sentiment. The community is actively debating the stock's potential as a pipeline-driven growth story, contrasting its commercial progress in oncology and infectious diseases against long-standing criticisms regarding its COVID-era legacy and the ongoing regulatory hurdles for its broad product lineup.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing significant volatility as investors weigh the company's long-term gene therapy pipeline against ongoing concerns regarding management leadership and a lack of clear near-term catalysts. The community is sharply divided, with bulls pointing to the company's revenue-generating DMD products and siRNA pipeline, while bears remain focused on the stock's persistent downtrend, high short interest, and frustration with the current executive team.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Promising Biotech Stocks To Keep An Eye On - December 9th

WAVE Life Sciences, Exicure, argenex, Danaher, Senti Biosciences, Abivax, and Vertex Pharmaceuticals are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool...

Exicure Stock Soars 40% After Stem Cell Drug Helps Most Patients Hit Phase 2 Goal — Traders Call It ‘Cheap’ At Current Levels

Equity

The company's stem cell drug burixafor helped nearly 90% of patients meet the Phase 2 goal.

Exicure, Inc. Loss At -$2.44 Mln In Q3

(RTTNews) - Exicure, Inc. (XCUR) reported Loss for third quarter of -$2.44 million...

Halper Sadeh LLC Encourages Exicure, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Exicure, Inc. (NASDAQ: XCUR) breached their fiduciary duties to shareholders. If you...

Exicure Stock Soars Over 25% On Acquisition Of GPCR Therapeutics’ U.S. Unit: Retail Chatter Spikes 

GPCR USA is noted for its work in developing cutting-edge treatments, including Opdivo, a widely used autoimmune disease therapy generating about $10 billion in annual revenue.

Exicure Stock Surges On Blood Cancer Portfolio Acquisition Plans, Nasdaq Compliance: Retail Exuberant

Chicago-based Exicure said it intends to receive technology transfer for GPCR Therapeutics’ CXCR4 inhibitor, along with its related patents and intellectual property. 


Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The firm's product pipeline includes Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Redwood City, CA.

Exicure Inc

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$2.31
Prev Close	$2.15
Open	$2.35
Dividend Yield	0.00%
50-Day Moving Average	$3.24
Beta	0.32
Avg. Volume	14,074.29
PE Ratio	-1.39

52-Week High	$9.50
52-Week Low	$1.71
Market Capitalization	$13.7M
EPS (Annual)	-$0.7854
Price to Book	6.53
Revenue Per Employee	$0.00

XCURExicure Inc

Fundamentals

Feed

News

Sentiment

Fundamentals

Info

Latest XCUR News